-+ 0.00%
-+ 0.00%
-+ 0.00%

VERRICA PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF LATE-BREAKING ABSTRACT HIGHLIGHTING POTENTIAL ABSCOPAL EFFECT OF VP-315 FOR THE TREATMENT OF BASAL CELL CARCINOMA AT THE UPCOMING 2026 SOCIETY FOR INVESTIGATIVE DERMATOLOGY ANNUAL MEETING

Reuters·04/09/2026 20:05:00

Please log in to view news